Cantor Fitzgerald Sticks to Its Hold Rating for LifePoint Health

In a report released today, Joseph France from Cantor Fitzgerald maintained a Hold rating on LifePoint Health (NASDAQ: LPNT), with a price target of $45. The company’s shares opened today at $51.90.

France wrote:

“Volumes fell and revenue was flat, but operating costs, primarily compensation and depreciation (reflecting write-offs and divestitures) were considerably lower than we expected, and adjusted EPS were ahead of our estimates and the FactSet consensus.”

According to TipRanks.com, France is a 4-star analyst with an average return of 9.1% and a 54.0% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Envision Healthcare.

LifePoint Health has an analyst consensus of Moderate Buy, with a price target consensus of $51.11.

See today’s analyst top recommended stocks >>

The company has a one-year high of $67.95 and a one-year low of $41.45. Currently, LifePoint Health has an average volume of 533.1K.

Based on the recent corporate insider activity of 11 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of LPNT in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

LifePoint Health, Inc. acts through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities. It also provides a broad range of general and specialized healthcare services. The company was founded on May 11, 1999 and is headquartered in Brentwood, TN.